Literature DB >> 26551617

Genetic studies of Russian patients with amyotrophic lateral sclerosis.

Elena V Lysogorskaia1, Nataliya Yu Abramycheva1, Mariya N Zakharova1, Mariya S Stepanova1, Anna A Moroz1, Alexey V Rossokhin1, Sergey N Illarioshkin1.   

Abstract

Our objective was to search for mutations in genes SOD1, TARDBP, C9orf72, ANG, ATXN2 and VEGF in Russian patients with amyotrophic lateral sclerosis (ALS). A group of 208 Russian patients with ALS was examined. Molecular genetic analysis was conducted using direct sequencing, fragment analysis, and real-time PCR. We found eight different point mutations in the SOD1 gene, with the frequency of mutations being 50% in familial ALS and 3% in sporadic ALS. No mutations were found in exon 6 of the TARDBP gene; however, deletion c.715-126delG in intron 5 of TARDBP was over-represented in ALS patients compared to controls (38% vs. 26.6%; χ(2 )= 13.17; p = 0.002). Hexanucleotide repeat expansion of the C9orf72 gene was revealed in 2.5% of sporadic ALS patients. Mutations in the ANG gene were identified in 1.5% of sporadic ALS patients. The presence of an intermediate number (28-33) of GAC repeats in the ATXN2 gene was observed significantly more often in the study group compared to the control group (5% vs. 1.7%; χ(2 )= 3.89; p = 0.0486). In the cohort examined, we found an association between the disease and the risk A-allele and the A/A genotype at the -2578С/А locus of the VEGF gene. In conclusion, we determined for the first time the genetic basis of ALS in a Russian population.

Entities:  

Keywords:  DNA; Genetics; RNA; SOD1; risk

Mesh:

Substances:

Year:  2015        PMID: 26551617     DOI: 10.3109/21678421.2015.1107100

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Frontotemporal Degener        ISSN: 2167-8421            Impact factor:   4.092


  1 in total

1.  Comparison of the clinical and cognitive features of genetically positive ALS patients from the largest tertiary center in Serbia.

Authors:  Ivan V Marjanović; Biljana Selak-Djokić; Stojan Perić; Milena Janković; Vladimir Arsenijević; Ivana Basta; Dragana Lavrnić; Elka Stefanova; Zorica Stević
Journal:  J Neurol       Date:  2017-04-25       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.